It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
To assess trends in the quality of care for COVID-19 patients at the ICU over the course of time in the Netherlands.
Methods
Data from the National Intensive Care Evaluation (NICE)-registry of all COVID-19 patients admitted to an ICU in the Netherlands were used. Patient characteristics and indicators of quality of care during the first two upsurges (N = 4215: October 5, 2020–January 31, 2021) and the final upsurge of the second wave, called the ‘third wave’ (N = 4602: February 1, 2021–June 30, 2021) were compared with those during the first wave (N = 2733, February–May 24, 2020).
Results
During the second and third wave, there were less patients treated with mechanical ventilation (58.1 and 58.2%) and vasoactive drugs (48.0 and 44.7%) compared to the first wave (79.1% and 67.2%, respectively). The occupancy rates as fraction of occupancy in 2019 (1.68 and 1.55 vs. 1.83), the numbers of ICU relocations (23.8 and 27.6 vs. 32.3%) and the mean length of stay at the ICU (HRs of ICU discharge = 1.26 and 1.42) were lower during the second and third wave. No difference in adjusted hospital mortality between the second wave and the first wave was found, whereas the mortality during the third wave was considerably lower (OR = 0.80, 95% CI [0.71–0.90]).
Conclusions
These data show favorable shifts in the treatment of COVID-19 patients at the ICU over time. The adjusted mortality decreased in the third wave. The high ICU occupancy rate early in the pandemic does probably not explain the high mortality associated with COVID-19.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 National Intensive Care Evaluation (NICE) Foundation, Amsterdam, The Netherlands; Amsterdam UMC, University of Amsterdam, Department of Intensive Care Medicine, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262)
2 National Intensive Care Evaluation (NICE) Foundation, Amsterdam, The Netherlands (GRID:grid.7177.6); Amsterdam UMC, University of Amsterdam, Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262)
3 National Intensive Care Evaluation (NICE) Foundation, Amsterdam, The Netherlands (GRID:grid.7177.6); Leiden University Medical Center, Department of Intensive Care Medicine, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978)
4 National Intensive Care Evaluation (NICE) Foundation, Amsterdam, The Netherlands (GRID:grid.10419.3d); University Medical Center, University of Utrecht, Department of Intensive Care Medicine, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234)
5 Maastricht University Medical Centre+, Department of Intensive Care Medicine, Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382); Maastricht University, Care and Public Health Research Institute (CAPHRI), Maastricht, The Netherlands (GRID:grid.5012.6) (ISNI:0000 0001 0481 6099)
6 National Intensive Care Evaluation (NICE) Foundation, Amsterdam, The Netherlands (GRID:grid.5012.6); Amsterdam UMC, University of Amsterdam, Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262)